Alaa Halawa – Medium

Alaa Halawa
in
MubadalaVentures

Metsera: Pioneering the Future of Obesity Therapeutics

For over seven years, our healthcare team has been expanding our ventures business, supporting companies that are revolutionizing…

4 min readApr 18, 2024

--

Metsera: Pioneering the Future of Obesity Therapeutics

--

Alaa Halawa
in
MubadalaVentures

Shifting the Clinical Research Paradigm

A discussion with Kent Thoelke, CEO of Paradigm, on our most recent investment in clinical trial transformation

3 min readJan 30, 2023

--

--

Alaa Halawa
in
MubadalaVentures

Our Investment in Pretzel Therapeutics: Creating a Powerhouse in the Mitochondria Field

As the “powerhouse of the cell,” mitochondria play a critical role in cell viability through a multitude of functions — from energy…

3 min readSep 13, 2022

--

Our Investment in Pretzel Therapeutics: Creating a Powerhouse in the Mitochondria Field

--

Alaa Halawa
in
MubadalaVentures

Navigating Biotech Funding Dynamics: Shifts in Public and Private Finance

Today, we are living through what many believe is the most exciting era in the biotech industry, an era characterized by an accelerated…

5 min readJul 22, 2022

--

Navigating Biotech Funding Dynamics: Shifts in Public and Private Finance

--

Alaa Halawa
in
MubadalaVentures

Healthcare Has a Data Problem. Here is How We Can Fix It.

Does access to seamless data matter in healthcare? To best answer this question, consider these two scenarios for patients with the same…

3 min readDec 17, 2021

--

1

--

1

Alaa Halawa
in
MubadalaVentures

Our Investment in Neumora: A Data Sciences-Driven Precision Approach to Treating Central Nervous…

Central nervous system (CNS) diseases, which include neurodegenerative disorders and neuropsychiatric illnesses, have placed a significant…

4 min readOct 7, 2021

--

Our Investment in Neumora: A Data Sciences-Driven Precision Approach to Treating Central Nervous…

--

Alaa Halawa
in
MubadalaVentures

Reimaging the Drug Value Chain

How EQRx is Improving Access to Life-Saving Medicines

5 min readAug 16, 2021

--

Reimaging the Drug Value Chain

--

Alaa Halawa

A Conversation with Chris Gibson, Co-Founder + CEO of Recursion

I sat down with Chris Gibson, Co-Founder and CEO of Recursion, off the heels of their recent IPO, to talk about his journey transforming…

7 min readJun 8, 2021

--

A Conversation with Chris Gibson, Co-Founder + CEO of Recursion

--

Alaa Halawa

The Future of Drug Discovery: Our Journey with Recursion Pharma

When Mubadala Capital launched its ventures platform in San Francisco three years ago, we had a simple mission: partner early with…

3 min readSep 10, 2020

--

The Future of Drug Discovery: Our Journey with Recursion Pharma

--

Alaa Halawa

Alaa Halawa

Venture Capital Investor at Mubadala Capital-Ventures, based in SF. Backing companies tackling some of the toughest challenges in life sciences and healthcare.

Following

Help
Status
About
Careers
Press
Blog
Privacy
Terms
Text to speech
Teams